Lumigan 0.01% Eye Drop

About Lumigan 0.01% Eye Drop

Lumigan 0.01% Eye Drop contains bimatoprost, a prostaglandin analogue that effectively reduces intraocular pressure (IOP) in patients with glaucoma and ocular hypertension. Manufactured by Allergan India Pvt Ltd, this ophthalmic solution works by increasing the outflow of aqueous humor through both the trabecular meshwork and uveoscleral routes, typically lowering IOP within 4 hours of administration with peak effect at approximately 8-12 hours. Beyond its primary indication for pressure reduction, bimatoprost has gained recognition for promoting eyelash growth by prolonging the anagen (growth) phase of the hair cycle. While similar pressure-lowering effects can be achieved with medications like Dorzox Eye Drop, bimatoprost offers the unique dual benefit of both therapeutic and cosmetic outcomes. For patients requiring additional ocular treatments, options such as Cyclomune Eye Drop may complement therapy for specific inflammatory conditions.

Dosage & Usage

The recommended dosage is one drop in the affected eye(s) once daily, preferably administered in the evening. Before application, remove contact lenses and wait at least 15 minutes before reinserting them. Tilt your head back, pull down the lower eyelid to create a small pocket, and instill one drop without touching the dropper tip to any surface to prevent contamination. Gently close your eyes for 1-2 minutes and apply light pressure to the inner corner of the eye to minimize systemic absorption. Do not exceed the prescribed frequency, as more frequent administration may actually reduce the IOP-lowering effect. If using multiple eye drops, wait at least 5 minutes between different medications. Each 3ml bottle provides approximately one month of treatment when used as directed.

Who Is It For?

Lumigan is indicated for adults diagnosed with open-angle glaucoma or ocular hypertension who require IOP reduction to prevent optic nerve damage and vision loss. It is particularly beneficial for patients who have not achieved adequate pressure control with first-line beta-blockers like Iobet Eye Drop or require combination therapy. Patients seeking cosmetic eyelash enhancement may also benefit under medical supervision. This medication is contraindicated in individuals with hypersensitivity to bimatoprost or benzalkonium chloride, and should be used cautiously in patients with inflammatory eye conditions, aphakia, or risk factors for macular edema. Pregnant or breastfeeding women should consult their healthcare provider before use. Regular eye examinations are essential to monitor therapeutic response and detect potential side effects such as iris pigmentation changes or periorbital fat atrophy.

Why Buy From SafeRxPills?

SafeRxPills is a licensed online pharmacy serving customers across Australia, the United Kingdom, the United States, and Canada with genuine WHO-GMP certified medications. We guarantee discreet delivery in plain, unmarked packaging within 7-14 business days to protect your privacy. Every Lumigan 0.01% Eye Drop is sourced directly from authorized manufacturers and stored under optimal conditions to ensure product integrity. Our secure ordering process and encrypted payment systems provide peace of mind, while our knowledgeable customer support team is available to answer your questions. Trust SafeRxPills for authentic ophthalmic solutions delivered directly to your door with complete confidentiality and pharmaceutical excellence.